Rather, it provides contingent support that can prolong axonal viability when glycolytic flux is insufficient (Asadollahi et al., 2024)
Vial Pricing The original vial format launched in March 2025 is the more economical option for lower doses: 2.5 mg vial: approximately 3,500 per week (around 14,000 per month) 5 mg vial: approximately 4,375 per week (around 17,500 per month) KwikPen Pricing Introduced in August 2025, the pre-filled KwikPen is more convenient and available in six strengths: 2.5 mg KwikPen: 13,125 per month 5 mg KwikPen: 16,406 per month 7.5 mg / 10 mg KwikPen: 20,625 per month 12.5 mg / 15 mg KwikPen: 25,781 per month In real terms, most patients should budget between 20,000 and 40,000 per month once consultation fees, dose escalation, follow-up appointments and basic monitoring are included
K.ShenY
(2023) 11:e1074
It is not medical advice, not a treatment plan, and not a recommendation to use retatrutide outside of a clinical trial or qualified medical care
doi:10.18632/aging.102682